Skip to main content

Science & Technology

NCI and FNL Researchers Turn Lessons Learned into Stepping Stones

Imagine you’re building a dresser. You find all the wood and hardware you need and have the instructions, the right tools, and a team of professionals to help. As you and your team put it together, you realize that while the frame is solid, the drawers don’t open and close correctly. You might be tempted to feel discouraged by the results. But a group of scientists from the National Cancer Institute (NCI), Frederick National Laboratory for Cancer Research (FNL), and other collaborating institutions share a different perspective in their recent work published in PNAS. They weren’t trying to assemble furniture but rather generate a new, better mouse model of the most common kidney cancer, clear cell renal cell carcinoma (ccRCC).

A Paradox and Alan Rein: Distinguished Retrovirologist Retires from the HIV DRP

In 1953, a teenaged Alan Rein read about what James Watson and Francis Crick famously called “the secret of life”—the double-helix structure of DNA, which had just been published in Nature. Captivated, Rein decided at that moment that he wanted to be a biochemist. Rein’s biochemistry aspirations shifted to virology during college, leading him to a 60-year career in the field, the last 45 years of which were spent at NCI Frederick, studying how retroviruses like murine leukemia virus and HIV assemble themselves and infect host cells while somehow evading the immune response.

Progress against RAS-driven cancers lauded at RAS Symposium, with more candidate treatments on the horizon

Researchers from around the world met in October to mark progress their field has made in developing drugs to treat cancers driven by the RAS oncogene, and to map out even more ways they can help cancer patients. “This is a great story about tackling an intractable disease that was said to be an impossible task,” said National Cancer Institute Director W. Kimryn Rathmell, M.D.

Combining Forces Creates Improved Anticancer Therapeutic

A scientist pushes a small gray button on a red metal box, activating a pump that shoots clear fluids from two syringes into a small compartment just a few square centimeters in size. From there, the mixture is forced through a thin tube into a thumb-sized glass vial, where it pools with a few small bubbles. That scientist, Caleb Anderson, Ph.D., a postdoctoral fellow at NCI Frederick’s Chemical Biology Laboratory, was hired to solve a problem, and this machine and its contents represent the solution he has spent months designing, calibrating, and testing.

Annual Spring Research Festival Gains Momentum, Shoots for More

Steak is always good, but it’s better with some sizzle. So said Kedar Narayan, Ph.D., in preparation for his keynote address at the 2024 Fort Detrick Spring Research Festival. Like a chef preparing a meal, he aimed for his lecture to offer the audience something particularly enticing.